BioReliance Director of Business Development Salaries in Crestview, FL
The average BioReliance Director of Business Development in Crestview, FL earns an estimated $215,432 annually, which includes an estimated base salary of $165,685 with a $49,747 bonus. BioReliance's Director of Business Development compensation is $49,130 more than the US average for a Director of Business Development. Director of Business Development salaries at BioReliance in Crestview, FL can range from $73,000 - $390,000.
In Crestview, FL, The Business Development Department at BioReliance earns $3,688 more on average than the Engineering Department.
Last updated 2 years ago.
- $165,685
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at BioReliance
In Crestview, FL, Directors of Business Development earn $4,372 more than Directors of Business Development.
Compensation at BioReliance by Department
In Crestview, FL, The Business Development Department averages $3,688 more than the Engineering Department, and $11,232 less than the Product Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to BioReliance reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to BioReliance reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at BioReliance Rate Their Compensation
The majority of Directors of Business Development at BioReliance believe they're compensated fairly. 50% of Directors of Business Development at BioReliance say they receive annual bonuses, and the vast majority (75%) are satisfied with their benefits. See more compensation ratings at BioReliance
